drug
doxercalciferol
Marketedupdated 3mo agoby Hospira Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying doxercalciferol
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 11, 2028
~1.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
FDA exclusivities (3)
- Jun 11, 2028M-14Method (3y)1.8y
- Jun 11, 2028M-14Method (3y)1.8y
- Jun 11, 2028M-14Method (3y)1.8y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that